Risk Factors of Initial Inappropriate Antibiotic Therapy and the Impacts on Outcomes of Neonates with Gram-Negative Bacteremia
Open Access
- 22 April 2020
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 9 (4), 203
- https://doi.org/10.3390/antibiotics9040203
Abstract
Background: Timely appropriate empirical antibiotic plays an important role in critically ill patients with gram-negative bacteremia. However, the relevant data and significant impacts have not been well studied in the neonatal intensive care unit (NICU). Methods: An 8-year (1 January 2007–31 December 2014) cohort study of all NICU patients with gram-negative bacteremia (GNB) in a tertiary-care medical center was performed. Inadequate empirical antibiotic therapy was defined when a patient did not receive any antimicrobial agent to which the causative microorganisms were susceptible within 24 h of blood culture sampling. Neonates with GNB treated with inadequate antibiotics were compared with those who received initial adequate antibiotics. Results: Among 376 episodes of Gram-negative bacteremia, 75 (19.9%) received inadequate empirical antibiotic therapy. The cause of inadequate treatment was mostly due to the pathogen resistance to prescribed antibiotics (88.0%). Bacteremia caused by Pseudomonas aeruginosa (Odds ratio [OR]: 20.8, P < 0.001) and extended spectrum β-lactamase (ESBL)-producing bacteria (OR: 18.4, P < 0.001) had the highest risk of inadequate treatment. Previous exposure with third generation cephalosporin was identified as the only independent risk factor (OR: 2.52, 95% CI: 1.18–5.37, P = 0.018). Empirically inadequately treated bacteremias were significantly more likely to have worse outcomes than those with adequate therapy, including a higher risk of major organ damage (20.0% versus 6.6%, P < 0.001) and infectious complications (25.3% versus 9.3%, P < 0.001), and overall mortality (22.7% versus 11.0%, P = 0.013). Conclusions: Inadequate empirical antibiotic therapy occurs in one-fifth of Gram-negative bacteremias in the NICU, and is associated with worse outcomes. Additional prospective studies are needed to elucidate the optimal timing and aggressive antibiotic regimen for neonates who are at risk of antibiotic-resistant Gram-negative bacteremia.Keywords
This publication has 38 references indexed in Scilit:
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology & Infection, 2012
- Consecutive Serratia marcescens multiclone outbreaks in a neonatal intensive care unitAmerican Journal of Infection Control, 2012
- The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care settingAmerican Journal of Infection Control, 2009
- Outbreak of Acinetobacter Infection in Extremely Low Birth Weight NeonatesThe Pediatric Infectious Disease Journal, 2009
- Impact of Empiric Antibiotic Use on Development of Infections caused by Extended-Spectrum β-Lactamase Bacteria in a Neonatal Intensive Care UnitThe Pediatric Infectious Disease Journal, 2008
- Outcome and prognostic factors in neonates with septic shock*Pediatric Critical Care Medicine, 2008
- Pathogen-Specific Early Mortality in Very Low Birth Weight Infants with Late-Onset Sepsis: A National SurveyClinical Infectious Diseases, 2005
- Risk Factors for Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in a Neonatal Intensive Care UnitInfection Control & Hospital Epidemiology, 2004
- Antimicrobial Use and the Influence of Inadequate Empiric Antimicrobial Therapy on the Outcomes of Nosocomial Bloodstream Infections in a Neonatal Intensive Care UnitInfection Control & Hospital Epidemiology, 2004
- Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogramJournal of Antimicrobial Chemotherapy, 2004